glp-1 nobel prize Appetite-regulating hormones in focus as first Prizes fall Lotte Bjerre Knudsen, 2025 Breakthrough

Semaglutide (Ozempic/Wegovy) is a GLP-1 receptor agonist that suppresses appetite

And it is also a necessary substrate for GPX4 enzymatic activity (Niu et al., 2021)

Serotonin is then either degraded or collected by the serotonin transporter (SERT)

In a more fragile world, where geopolitical instability has the potential to cause knock-on effects for commercial activities, Stevanato Groups highly integrated service offering and global reach can provide greater control and introduce higher levels of efficiency and continuity of supply throughout the supply chain, from sourcing raw materials through to the robust production of patient-friendly autoinjectors and pen injectors that are fully compliant with current regulatory requirements